Sign Up to like & get
recommendations!
1
Published in 2020 at "Blood Cancer Journal"
DOI: 10.1038/s41408-020-0277-6
Abstract: Activating MYD88 mutations promote pro-survival signaling through BTK and HCK, both targets of ibrutinib. Despite high response rates, complete responses to ibrutinib are lacking, and other MYD88 triggered pro-survival pathways may contribute to primary drug…
read more here.
Keywords:
pro survival;
mutated myd88;
syk;
myd88 mutated ... See more keywords